Immunosenescence and cancer

Area of Science:

• Oncology
• Immunology
• Gerontology

Background:

• The immune system plays a dual role in cancer, potentially combating or promoting tumor development.
• Age is a significant risk factor for solid cancers, associated with systemic physiological alterations.
• Aging affects both innate and adaptive immunity, with profound changes observed in T cells.

Purpose of the Study:

• To investigate the impact of age-related immune system changes on cancer development and progression.
• To elucidate how alterations in T cell function and phenotype contribute to decreased anti-tumor immunity in the elderly.
• To emphasize the importance of studying the tumor microenvironment and immune response in aging cancer patients.

Main Methods:

• Review of existing literature on immune system aging and cancer.
• Analysis of age-associated changes in immune cell function, particularly T cells.
• Exploration of the link between low-grade inflammation and impaired anti-tumor responses.

Main Results:

• Aging leads to significant alterations in the adaptive immune system, especially T cells.
• Age-related immune changes can diminish the body's capacity to fight emerging tumors.
• These immune modifications may create an environment that favors cancer development.

Conclusions:

• Age-related immune decline, characterized by altered T cell function and chronic inflammation, compromises anti-tumor surveillance.
• Understanding the interplay between aging immunity and cancer is essential for developing targeted interventions in elderly patients.
• A holistic approach, considering both cancer cells and their immune microenvironment, is vital for improving cancer care in older adults.